Tyra Biosciences Inc
(TYRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 302,182 | 312,823 | 0 | 0 | N/A |
| TOTAL | $304,057 | $313,501 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,027 | 779 | N/A | N/A | N/A |
| Other Non-Current Assets | 1,617 | 1,690 | 0 | 0 | 0 |
| TOTAL | $2,644 | $2,469 | $N/A | $N/A | $N/A |
| Total Assets | $306,701 | $315,970 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 599 | 2,068 | 0 | 0 | 0 |
| Accrued Expenses | 2,815 | 2,565 | 0 | 0 | N/A |
| TOTAL | $3,616 | $4,768 | $0 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,348 | 1,471 | 0 | 0 | 0 |
| TOTAL | $1,348 | $1,471 | $N/A | $N/A | $N/A |
| Total Liabilities | $4,964 | $6,239 | $0 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,605 | 41,266 | N/A | N/A | N/A |
| Common Shares | 4 | 4 | 0 | 0 | N/A |
| Retained earnings | -40,371 | -30,441 | 0 | 0 | N/A |
| TOTAL | $301,737 | $309,731 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $306,701 | $315,970 | $0 | $0 | $0 |